Bohm Parker E, Chen John J, Bhatti Tariq M, Eggenberger Eric R
Department of Neurology (PEB, ERE), Mayo Clinic, Jacksonville, Florida; Department of Neurology (JJC, TMB), Mayo Clinic, Rochester, Minnesota; Department of Ophthalmology (JJC, TMB), Mayo Clinic, Rochester, Minnesota; Department of Ophthalmology (ERE), Mayo Clinic, Jacksonville, Florida; and Neurosurgery (ERE), Mayo Clinic, Jacksonville, Florida.
J Neuroophthalmol. 2020 Sep;40(3):385-397. doi: 10.1097/WNO.0000000000001005.
Over the past decade, there has been a remarkable advancement in the understanding of autoimmune etiologies of encephalitis. The first identified generation of paraneoplastic encephalitis tends to occur in older populations, responds poorly to immunotherapy, and is mediated by T-cell damage with antibodies directed toward intracellular antigens. A new generation of autoimmune encephalitides has been described, which are mediated by antibodies to cell-surface proteins, tend to occur in younger individuals, are less frequently associated with malignancy, and often respond better to treatment compared to their intracellular antigen-related paraneoplastic counterparts. This review will focus on several specific antibody-mediated autoimmune encephalitides with neuro-ophthalmic pertinence.
Literature review and personal clinical experience.
Several of the antibody-mediated encephalitides, specifically N-methyl-D-aspartate receptor, dipeptidyl-peptidase-like protein 6, glial fibrillary acidic protein, metabotropic glutamate receptor 1 (mGluR1), gamma-aminobutyric acid receptor, glutamic acid decarboxylase 65 (GAD65), collapsing response mediator protein 5 (CRMP5), and kelch-like protein 11 (KLHL11), contain features of neuro-ophthalmic interest.
The novel cell-surface protein-directed autoimmune encephalitis group can present with a wide range of afferent and efferent neuro-ophthalmic manifestations. Neuro-ophthalmologists should be familiar with these antibody-associated syndromes, which are treatable and often require a high index of suspicion for diagnosis.
在过去十年中,人们对脑炎自身免疫病因的认识有了显著进展。最早发现的第一代副肿瘤性脑炎往往发生在老年人群中,对免疫治疗反应不佳,由针对细胞内抗原的抗体介导的T细胞损伤所致。现已描述了新一代自身免疫性脑炎,它们由针对细胞表面蛋白的抗体介导,往往发生在较年轻个体中,与恶性肿瘤的关联较少,并且与细胞内抗原相关的副肿瘤性脑炎相比,通常对治疗反应更好。本综述将聚焦于几种与神经眼科相关的特定抗体介导的自身免疫性脑炎。
文献综述及个人临床经验。
几种抗体介导的脑炎,特别是N-甲基-D-天冬氨酸受体、二肽基肽酶样蛋白6、胶质纤维酸性蛋白、代谢型谷氨酸受体1(mGluR1)、γ-氨基丁酸受体、谷氨酸脱羧酶65(GAD65)、塌陷反应介导蛋白5(CRMP5)和kelch样蛋白11(KLHL11)具有神经眼科相关特征。
新型细胞表面蛋白导向的自身免疫性脑炎可表现出广泛的传入和传出神经眼科表现。神经眼科医生应熟悉这些与抗体相关的综合征,它们是可治疗的且通常需要高度怀疑才能诊断。